Date published: 2025-12-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

GPRC5C Inhibitors

GPRC5C inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the GPRC5C protein, also known as G protein-coupled receptor family C group 5 member C. GPRC5C is a member of the G protein-coupled receptor (GPCR) superfamily, a diverse group of cell surface receptors involved in cellular signaling and responses to various extracellular stimuli. While the precise functions of GPRC5C are not fully understood, it is known to be expressed in various tissues, including the lung and gastrointestinal tract, and may play a role in processes related to cell proliferation, differentiation, and responses to specific ligands or environmental cues. Inhibitors of GPRC5C are developed to interfere with its function or activity, potentially influencing the cellular processes and signaling pathways regulated by this receptor. The mechanisms by which GPRC5C inhibitors function can vary based on their chemical structures and binding properties. Some inhibitors may directly interact with GPRC5C, preventing its activation by ligands or its coupling to intracellular signaling pathways. Others may modulate the stability or conformation of GPRC5C, affecting its ability to respond to extracellular cues. By inhibiting GPRC5C, these compounds have the potential to impact cellular responses mediated by this receptor, which may include signaling events related to cell growth, differentiation, or responses to specific physiological or environmental factors. Ongoing research in this field aims to elucidate the precise mechanisms and downstream effects of GPRC5C inhibition, contributing to our understanding of its role in cellular biology and GPCR-mediated signaling pathways.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA, a PKC activator, may influence GPRC5C expression by modulating protein kinase C (PKC) mediated signaling pathways.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin, an adenylate cyclase activator, could potentially affect GPRC5C expression through its role in increasing intracellular cAMP levels.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059, a MAPK inhibitor, may modulate GPRC5C expression by affecting the MAPK/ERK signaling pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002, a PI3K inhibitor, could influence GPRC5C expression by modulating PI3K/Akt signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580, a p38 MAPK inhibitor, might alter GPRC5C expression by affecting the p38 MAPK pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126, another MEK inhibitor, may affect GPRC5C expression through its impact on the MAPK/ERK pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin, an mTOR inhibitor, could potentially modulate GPRC5C expression through its effects on cell growth and autophagy.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Gefitinib, an EGFR inhibitor, might impact GPRC5C expression by modulating EGFR signaling pathways.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib, a kinase inhibitor, may influence GPRC5C expression by targeting multiple kinases involved in cell signaling.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Imatinib, a tyrosine kinase inhibitor, could alter GPRC5C expression through its effects on BCR-ABL and other kinases.